Bank of Montreal
VYNT

Bank of Montreal’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Bank of Montreal’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,000
Closed -$37K – 4002
2021
Q2 		$37K Buy
+2,000
New +$37.3K ﹤0.01% 3458
2020
Q1 		– Sell
-2,000
Closed -$60K – 4896
2019
Q4 		$60K Buy
+2,000
New +$47.9K ﹤0.01% 3763
2017
Q4 		– Sell
-161
Closed -$66K – 4381
2017
Q3 		$66K Sell
161
-34
-17% -$17.7K ﹤0.01% 3131
2017
Q2 		$116K Hold
195
– – ﹤0.01% 2923
2017
Q1 		$120K Buy
+195
New +$69.4K ﹤0.01% 2734
2015
Q1 		– Sell
-4,110
Closed -$4.12M – 4252
2014
Q4 		$4.12M Sell
4,110
-1,514
-27% -$1.52M ﹤0.01% 1105
2014
Q3 		$7.59M Buy
5,624
+165
+3% +$236K 0.01% 918
2014
Q2 		$9.25M Buy
5,459
+1,342
+33% +$2.55M 0.01% 839
2014
Q1 		$9.32M Buy
+4,117
New +$10.5M 0.01% 696

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BF
Blankinship & Foster Solana Beach, California $495M AUM 21.93% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Montreal's VYNT Position: Q3 2021 in Review

Bank of Montreal sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q3 2021, closing a stake of 2,000 shares — an estimated $37K sold.

Bank of Montreal first reported a position in VYNT in Q1 2014 and held it in 9 quarters. The position peaked at $9.32M in Q1 2014. 23 funds tracked by Wall St. Rank hold VYNT as of Q3 2021.

  • Bank of Montreal reported no remaining Vyant Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Bank of Montreal sold 2,000 Vyant Bio, Inc. Common Stock shares in Q3 2021, an estimated $37K.
  • Bank of Montreal first reported a position in Vyant Bio, Inc. Common Stock in Q1 2014 and held it in 9 quarters.
  • Bank of Montreal's Vyant Bio, Inc. Common Stock position peaked at $9.32M in Q1 2014.
  • 23 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q3 2021.

Based on Bank of Montreal's 13F filing for Q3 2021, filed 12 Nov 2021.